Nkarta Inc Sustainability Reports
Nkarta, Inc. is a clinical-stage biopharmaceutical company that develops engineered natural killer cell therapies for cancer and autoimmune diseases. The company leverages its proprietary cell expansion and engineering technologies to manufacture allogeneic, off-the-shelf therapeutic candidates.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00JXHS9H6
5 reports from 2020 to 2025
Company Profile
Nkarta, Inc. is a clinical-stage biopharmaceutical company that develops engineered natural killer cell therapies for cancer and autoimmune diseases. The company leverages its proprietary cell expansion and engineering technologies to manufacture allogeneic, off-the-shelf therapeutic candidates.
Reports
5 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
